Page 32 - Alkermes News Today

Datalys Market Analysis Get Free Sample Report: Tocolysis Drugs Industry Market Research Report 2023-2031Datalys recently introduced Global Tocolysis

Alkermes (NASDAQ:ALKS – Get Rating) had its target price boosted by Piper Sandler from $35.00 to $37.00 in a report issued on Wednesday, The Fly reports. Several other research firms have also issued reports on ALKS. HC Wainwright increased their price target on shares of Alkermes from $32.00 to $34.00 in a research report on […]

Alkermes plc (NASDAQ:ALKS – Get Rating) Director Cato T. Laurencin sold 2,800 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $31.50, for a total value of $88,200.00. Following the transaction, the director now owns 7,479 shares of the company’s stock, […]

Alkermes (NASDAQ:ALKS – Get Rating) had its price objective lifted by Mizuho from $36.00 to $40.00 in a report released on Wednesday morning, The Fly reports. Several other research analysts have also recently issued reports on the company. Stifel Nicolaus upped their price target on Alkermes to $30.00 in a report on Thursday, February 16th. […]

Sarissa Capital Management LP today issued a presentation detailing the need for shareholder representation on the board of Alkermes accessible at the link below: Presentation:... | June 9, 2023

Alkermes (NASDAQ:ALKS – Get Rating) had its target price increased by Piper Sandler from $35.00 to $37.00 in a report issued on Wednesday, The Fly reports. Piper Sandler’s price target would suggest a potential upside of 17.31% from the stock’s current price. Several other brokerages have also issued reports on ALKS. HC Wainwright increased their […]

Sarissa Capital Management LP ("Sarissa") today issued a presentation detailing the need for shareholder representation on the board of Alkermes (NASDAQ: ALKS) accessible at the link below: Presentation:

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today announced that it has filed an investor presentation with the U.S. Securities and Exchange...

Strategic, Operational and Governance Enhancements Have Driven Strong Stock Price Performance and TSR Outperformance in Comparison to Peers Reiterates Board's Belief that Sarissa Nominees

In 2021, the Alkermes Inspiration Grants program funded nonprofit programs providing support for patient communities in the areas of addiction, serious mental illness and cancer. Watch this video to hear grantees’ perspectives about the impact of AIG.